Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04186260 · ClinicalTrials.gov registry record · NA
A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04186260: Completed NA study, sponsored by University of Arizona.
NCT04186260 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04186260, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Using a small Randomized Controlled Trial (RCT) study design, PNPLA3 risk allele carriers (CG/GG genotype) with NAFLD, will be assigned 2:1 to a tailored NAFLD-specific weight loss intervention compared to a wait-list control group.
Primary Outcome
The number of Mexican-American men who express interest in participation.
Interventions
- OTHER Wait-list control
- BEHAVIORAL NAFLD-specific weight loss intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-02-05 |
| Est. Completion | 2025-05-30 |
| Phase | NA |
What the finished NCT04186260 record still lists
NCT04186260 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Wait-list control is the first listed.
NCT04186260 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04186260 about?
NCT04186260 is a clinical study titled "A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men". Using a small Randomized Controlled Trial (RCT) study design, PNPLA3 risk allele carriers (CG/GG genotype) with NAFLD, will be assigned 2:1 to a tailored NAFLD-specific weight loss intervention compared to a wait-list control group.
What is the current status of trial NCT04186260?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2024-02-05. Estimated completion is 2025-05-30.
What interventions are being tested in trial NCT04186260?
The interventions under investigation include: Wait-list control (OTHER), NAFLD-specific weight loss intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04186260?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04186260's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI